Synergetic immunotherapies and current molecular targets in oral cancer treatment

Synergetic immunotherapies and current molecular targets in oral cancer treatment

The development of cancer therapies depends on identifying exploitable differences between the host immune response and the tumorigenicity. These include anatomic, metabolic, cell cycle kinetics, and presumed antigenic differences between the normal tissue and tumor cells. Immunotherapy also called...

Full description

Bibliographic Details
Main Authors: Govind Raj K Nalabolu, N Pallavi, Santhosh Kumar S Hiremath, Smita S Birajdar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Dr. NTR University of Health Sciences
Subjects:
Adoptive cell therapy
cancer vaccine
complements
dendritic cells
immunotherapy
natural killer cells
oral cancer
tumor-targeted monoclonal antibodies
tumor microenvironment
Online Access:http://www.jdrntruhs.org/article.asp?issn=2277-8632;year=2017;volume=6;issue=2;spage=73;epage=81;aulast=Nalabolu

Internet

http://www.jdrntruhs.org/article.asp?issn=2277-8632;year=2017;volume=6;issue=2;spage=73;epage=81;aulast=Nalabolu

Similar Items